Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Earnings per Share (Diluted) is $2.63 as of Feb. 2026. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $51.87 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 510 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 52.16% on this metric.
During the past 12 months, COSMOS Pharmaceutical's average EPS without NRIGrowth Rate was 2.50% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 10.40% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 6.50% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 8.10% per year.
During the past 13 years, COSMOS Pharmaceutical's highest 3-Year average EPS without NRI Growth Rate was 31.20% per year. The lowest was -0.50% per year. And the median was 13.60% per year.
COSMOS Pharmaceutical (OTCPK:CSMYF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
COSMOS Pharmaceutical Earnings per Share (Diluted) Related Terms
COSMOS Pharmaceutical Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Earnings per Share (Diluted) Chart
COSMOS Pharmaceutical Earnings per Share (Diluted) Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's PE Ratio distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's PE Ratio falls into.
COSMOS Pharmaceutical Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
COSMOS Pharmaceutical's Earnings Per Share (Diluted) for the fiscal year that ended in May. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $2.63 mean?
COSMOS Pharmaceutical (CSMYF) has a Earnings per Share (Diluted) of $2.63 as of Feb. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on COSMOS Pharmaceutical and its competitors. According to the industry distribution chart, COSMOS Pharmaceutical ranks #266 out of 510 companies in the Healthcare Providers & Services industry, placing it in the top 52.2%.
Is COSMOS Pharmaceutical's Earnings per Share (Diluted) too high?
COSMOS Pharmaceutical's current Earnings per Share (Diluted) is $2.63. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.55. COSMOS Pharmaceutical's value of $2.63 is 77.2% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #266 out of 510 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Earnings per Share (Diluted) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #266 out of 510 companies for Earnings per Share (Diluted). This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.55. COSMOS Pharmaceutical's value of $2.63 is 77.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.55, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Earnings per Share (Diluted) of $2.63 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Earnings per Share (Diluted) is $2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $51.87, compared to a current price of $37.06 — trading 28.6% below its estimated fair value. The current Earnings per Share (Diluted) is $2.63 and 77.2% below the Healthcare Providers & Services industry median of 11.55. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Earnings per Share (Diluted) is $2.63 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 28.6% below its estimated GF Value™ of $51.87.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Earnings per Share (Diluted): $2.63
GF Value™: $51.87 vs. price of $37.06 (28.6% below fair value)
Industry Position: 77.2% below the Healthcare Providers & Services median (#266 of 510)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
